Interphase karyotypic analysis of chromosomes 11, 17 and X in invasive squamous-cell carcinoma of the cervix: Morphological correlation with HPV infection

International Journal of Cancer

Volumn 70, Issue 5, 1997, Pages 502-507

  Southern, Shirley A ^a   Herrington, C Simon ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME ABERRATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; INTERPHASE; KARYOTYPING; PAPILLOMA VIRUS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; X CHROMOSOME;

CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; HUMANS; KARYOTYPING; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS; X CHROMOSOME;

EID: 0030891642     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970304)70:5<502::AID-IJC2>3.0.CO;2-1     Document Type: Article

References (26)

1. ALTMAN, D.G., Practical statistics for medical research, Chapman and Hall, London (1991).
2. BERUMEN, J., UNGER, E.R., CASAS, L. and FIGUEROA, P., Amplification of human papillomavirus type-16 and type-18 in invasive cervical cancer. Hum. Pathol., 26, 676-681 (1995).
3. BETHWAITE, P., KORETH, J., HERRINGTON, C.S. and MCGEE, J.O.D., Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical cancer. Brit. J. Cancer, 71, 814-818 (1995).
4. BOSCH, F.X., SCHWARZ, E., BOUKAMP, P., FUSENIG, N.E., BARTSCH, D. and ZUR HAUSEN, H., Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells. J. Virol., 64, 4743-4754 (1990).
5. COOPER, K., HERRINGTON, C.S., STICKLAND, J.E., EVANS, M.F. and MCGEE, J.O.D., Episomal and integrated HPV in cervical neoplasia demonstrated by nonisotopic in situ hybridization. J. clin. Pathol. 44, 990-996 (1991).
6. HERRINGTON, C.S., Human pupillomaviruses and cervical neoplasia I: virology, classification, pathology and epidemiology. J. clin. Pathol., 47, 1066-1072 (1994a).
7. HERRINGTON, C.S., Interphase cytogenetics: principles and applications. J. Histotechnol., 17, 219-234 (1994b).
8. HERRINGTON, C.S., Human papillomaviruses and cervical neoplasia II: interaction with other factors. J. clin. Pathol., 48, 1-6 (1995).
9. HERRINGTON, C.S., BURNS, J., GRAHAM. A.K., BHATT, B. and MCGEE, J.O.D., Interphase cytogenetics using biotin and digoxigenin labelled probes I: relative sensitivity of both reporter molecules for HPV 16 detection in CaSki cells. J. din. Pathol., 42, 592-600 (1989).
10. HBRRINGTON, C.S., COOPER, K. and MCGEE, J.O.D., Interphase cytogenetics: analysis of numerical chromosome aberrations in isolated cells. J. Pathol., 175, 283-295 (1995).
11. HOPMAN, A.H., VAN HOOREN, E., VAN DE KAA, C., VOOUS, P.G. and RAMAEKERS, F.C.S., Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod. Pathol., 4, 503-513 (1991).
12. HOPMAN, A.H.M., PODDIGHE, P. MOESKER, O. and RAMAEKERS, F.C.S., Interphase cytogenetics: an approach to the detection of genetic aberrations in tumours. In: C.S. Herrington and J.O'D. McGee (eds.), Diagnostic molecular pathology: a practical approach, vol. 1, pp. 141-167, Oxford University Press, Oxford (1992).
13. JESUDASAN, R.A., RAHMAN, R.A., CHANDRASHEKHARAPPA, S., EVANS, G.A. and SRIVATSAN, E.S., Deletion and translocation of chromosome 11q23 sequences in cervical carcinoma cell lines. Amer. J. hum. Genet., 56, 705-715 (1995).
14. KURMAN, R.J., NORRIS, H.J. and WILKINSON, E., Tumors of the cervix, vagina and vulva. Atlas of tumor pathology (3rd series, Fase. 4), Armed Forces Institute of Pathology (1992).
15. MATLASHEWSKI, G., OSBORN, K., BANKS, L., STANLEY, M. and CRANVFORD, L., Transformation of primary human fibroblast cells with human papilloma-virus type 16 DNA and EJ-ras. Int. J. Cancer; 42, 232-238 (1988).
16. MCCANCE, D.J., KOPAN, R., FUCHS, E. and LAIMINS, L.A., Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc. nat. Acad. Sci. (Wash.), 85, 7168-7173 (1988).
17. MICALE, M.A., VISSCHER, W., GULINO, S.E. and WOLMAN, S.R., Chromosomal aneuploidy in proliferative breast disease. Hum. Pathol., 25, 29-35 (1994).
18. MITRA, A.B., MURTY, V.V.V.S., PRATAP, M., SODHANI, P. and CHAGANTI, R.S.K., Erb-B2 (Her2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix. Cancer Res., 54, 637-639 (1994).
19. PADBERG, B.C., ARPS, H., FRANKE, U., THIEDEMANN, C., REHPENNVNG, W., STEGNER, H.E., LIETZ, H., SCHRODER, S. and DIETEL, M., DNA cytophotometry and prognosis in ovarian tumours of borderline malignancy - a clinicomorphological study of 80 cases. Cancer, 69, 2510-2514 (1992).
20. SCULLY, R.E., BONFIGLIO, T.A., KURMAN, R.J., SILVERBERG, S.G. and WILKINSON, E.J., Histological typing of female genital tract tumours. World Health Organisation International Histalogical Classification of Tumours, Springer-Verlag, Berlin (1994).
21. SOUTHERN, S.A. and HERRINGTON, C.S., The assessment of intra-tumoural karyotypic heterogeneity by interphase cytogenetics in paraffin wax sections. J. clin. Pathol. mol. Pathol., 49, M283-M289 (1996).
22. SREEKANTAIAH, C., DE BRAEKELEER, M. and HAAS, O., Cytogenetic findings in cervical carcinoma: a statistical approach. Cancer Genet. Cytogenet., 53, 75-81 (1991).
23. TAKAHASHI, Y., TAKENAKA, A., ISHIGURO, T. and NODA, Y., Intratumoral DNA heterogencity correlated with lymph node involvement and surgical staging in epithelial ovarian cancer by flow cytometry. Cancer, 73, 3011-3014 (1994).
24. TEYSSIER, J.R., The chromosomal analysis of human solid tumours: a triple challenge. Cancer Genet. Cytogenet., 37, 103-125 (1989).
25. WOLMAN, S.R., MACOSKA, J.A., MICALE, M.A. and SAKR, W.A., An approach to definition of genetic alterations in prostate cancer. Diagn. mol. Pathol., 1, 192-199 (1992).
26. ZUR HAUSEN, H., Intracellular surveillance of persisting viral infections: human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet, ii, 489-491 (1986).